Irinotecan Hydrochloride
NDC 60505-6272, Irinotecan Hydrochloride, injection, solution, from Apotex Corp..
- Product NDC
- 60505-6272
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203380
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6272 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IRINOTECAN HYDROCHLORIDE20 mg/mL
Pharmacologic classes
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-6272-1 | 60505627201 | 1 VIAL, SINGLE-USE in 1 CARTON (60505-6272-1) / 5 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8fe98987-e526-4729-a8f4-c7230f424108Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=60505-6272
Use it
Look up 60505-6272 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-6272 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-6272. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.